Clinical Trials List
2017-06-01 - 2026-12-31
Phase III
Terminated5
ICD-10C64
Malignant neoplasm of kidney, except renal pelvis
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Hsiao-Jen Chung Division of Radiology
- Yi-Hsiu Huang Division of Radiology
- Tzu-chun Wei Division of Radiology
- 沈書慧 Division of Radiology
- Yen-Hwa Chang Division of Radiology
- 潘競成 Division of Urology
- Tzu-Ping Lin Division of Urology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Ching-Chan Lin Division of Radiation Therapy
- 陳冠亨 Division of Radiation Therapy
- Che-Hung Lin Division of Radiation Therapy
- Yi-Huei Chang Division of Radiation Therapy
- Po-Fan Hsieh Division of Radiation Therapy
- Hsi-Chin Wu Division of Radiation Therapy
- Chi-Rei Yang Division of Radiation Therapy
- Su-Peng Yeh Division of Radiation Therapy
- Wei-Ching Lin Division of Radiation Therapy
- Chi-Ping Huang Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- CHING-CHU LU Division of Nuclear Medicine
- - - Division of Urology
- YI-KAI CHANG Division of Urology
- - - Division of Urology
- PO-MING CHOW Division of Urology
- Yeong-Shiau Pu Division of Urology
- YEN-HENG LIN Division of Radiology
- YU-CHUAN LU Division of Urology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Audit
None
Co-Principal Investigator
- Cheng-Kuang Yang Division of Urology
- 盧嘉文 Division of Urology
- Chuan-Shu Chen Division of Urology
- 洪晟鈞 Division of Urology
- Cheng-Che Chen Division of Urology
- Shian-Shiang Wang Division of Urology
- 王樹吉 Division of Urology
- Jian-Ri Li Division of Urology
- 裘坤元 Division of Urology
- 熊小澐 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
Audit
None
Taiwan National PI
Co-Principal Investigator
- Yung-Chia Kao Division of Hematology & Oncology
- 劉忠一 Division of Hematology & Oncology
- 張英勛 Division of Hematology & Oncology
- Kai-Jie Yu Division of Hematology & Oncology
- Wen-Cheng Chang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
950 participants